HONG KONG, Apr 13, 2026 - (ACN Newswire via SeaPRwire.com) - This article serves as a foundational study for the Noah Medical deep-dive series, aiming to help investors establish a core framework for assessing value in the medical robotics industry.As the medical robotics sector continues to gain momentum, market discussion tends to center on technical specifications and commercialization progress. Yet from a long-term investment perspective, these dimensions alone cannot explain the divergence in value among companies. What truly determines a medical robotics company's long-term worth is not the technology itself—but the level of clinical problem it solves.The global medical robotics market is projected to grow from roughly USD 70–80 billion in 2023 to over USD 200 billion by around 2030, representing a compound annual growth rate above 15%. More notable, however, is the structural shift underway: the industry's core growth driver is moving rapidly from the "surgical execution end" toward the "diagnostic gateway"—that is, earlier disease detection and more accurate early-stage diagnosis and intervention. Competition around device performance is giving way to comp...

香港, 2026年4月13日 - (亚太商讯 via SeaPRwire.com) - 本文系 Noah Medical 系列深度报告的铺垫性研究，旨在帮助投资者建立医疗机器人行业的核心价值判断框架在医疗机器人赛道持续升温的当下，市场的讨论往往聚焦于技术参数与商业化进展。然而，从长期投资视角来看，这些维度并不足以解释企业之间的价值分化。真正决定一家医疗机器人公司长期价值的，是其所解&#...